杂合COL4A3/COL4A4突变:冰山隐藏的部分?
该回顾性研究分析了1990至2019年间转诊的25个家系中24例先证者及29例患病亲属,均携带COL4A3/COL4A4杂合突变。随访中9例出现蛋白尿,4例进展至慢性肾脏病,3例需肾脏替代治疗。作者建议评估需结合家族史、基因分析及病理,并提出应考虑不同的Alport综合征定义。
要点
- 杂合COL4A3/COL4A4突变患者中部分可进展至慢性肾脏病,需肾脏替代治疗。
- 血尿呈连续世代传递,而慢性肾脏病见于11个家系的非连续世代。
- 17例(32%)行肾活检,12例符合Alport综合征,5例符合薄基底膜肾病。
核心结论
- 尽管文献描述这类患者病程良性,但相当比例存在疾病进展风险。
- 作者建议评估这类患者必须考虑家族史、基因分析和病理发现。
- 与文献比较后,作者认为应考虑不同的Alport综合征定义。
研究设计与样本
- 回顾性分析1990至2019年间转诊的携带致病性杂合COL4A3/COL4A4突变患者。
- 先证者定义为家庭中首个被诊断的儿童。
- 研究纳入25个家系中24例先证者和29例患病亲属。
主要发现
- 随访期间9例出现蛋白尿,中位年龄15.7岁(范围5.6-33)。
- 6例在临床诊断时即有蛋白尿,4例进展至慢性肾脏病(3例分别在25、45、53岁需肾脏替代治疗,1例46岁时为CKD 2期)。
- 24.5%的患者观察到肾外受累。
- 血尿呈连续世代传递,而慢性肾脏病见于11个家系的非连续世代,中位年龄53岁(范围16-80)。
- 17例(32%)行肾活检,12例符合Alport综合征,5例符合薄基底膜肾病。
临床怎么用
- 作者建议这类患者的评估必须考虑家族史、基因分析和病理发现。
- 作者认为应考虑不同的Alport综合征定义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Single mutations in COL4A3/COL4A4 genes have been described in patients with autosomal dominant Alport syndrome and thin basement membrane nephropathy, without a shared definition of these patients within the medical community. We aimed to better categorize this clinical entity by examining clinical manifestations, family history, pathological features and genetics. METHODS: We retrospectively analyzed patients with causative heterozygous COL4A3/COL4A4 mutations referred to us between 1990 and 2019. Index cases were defined as children who were the first to be diagnosed in their families. RESULTS: The study included 24 index cases and 29 affected relatives, belonging to 25 families with a heterozygous mutation in the COL4A3/COL4A4 genes. During the follow-up, nine patients developed proteinuria [median age 15.7 years (range 5.6-33)], six at clinical diagnosis and four with progression toward chronic kidney disease (CKD) (three required kidney replacement therapy at 25, 45 and 53 years and one had CKD Stage 2 at 46 years). Extrarenal involvement was observed in 24.5% of patients. Hematuria was transmitted in consecutive generations, while CKD was reported in nonconsecutive generations of 11 families [median age 53 years (range 16-80)]. Seventeen patients (32%) underwent kidney biopsy: findings were consistent with Alport syndrome in 12 cases and with thin basement membrane nephropathy in 5 cases. CONCLUSIONS: Despite the benign course for these patients described in the literature, a significant percentage is at risk for disease progression. Consequently, we suggest that the assessment of these patients must take into account family history, genetic analysis and pathologic findings. After comparison with the literature, our data suggest that a different definition for Alport syndrome must be considered.
引用
- Mastrangelo A, Madeira C, Castorina P, et al. Heterozygous COL4A3/COL4A4 mutations: the hidden part of the iceberg? Nephrol Dial Transplant. 2022. PMID: 35090027. doi:10.1093/ndt/gfab334
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。